We are live on
!
Find out more
CL
CRCM LP Portfolio holdings
AUM
$141M
1-Year Est. Return
153.09%
This Fund
S&P 500
This Quarter
Est. Return
+3.88%
1 Year Est. Return
+153.09%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$154M
AUM Growth
+$16.2M
(+12%)
Cap. Flow
+$33.6M
Cap. Flow
% of AUM
21.74%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
1
Increased
2
Reduced
1
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GRAL
GRAIL Inc
GRAL
|
+$38.6M |
| 2 |
iShares Bitcoin Trust
IBIT
|
+$33.6M |
| 3 |
OMIC
Singular Genomics Systems, Inc. Common Stock
OMIC
|
+$898K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Gold Trust
IAU
|
+$37.6M |
| 2 |
GRND.WS
Grindr Inc. Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
GRND.WS
|
+$1.3M |
| 3 |
NexGen Energy
NXE
|
+$358K |
| 4 |
Lifezone Metals Ltd Warrants
LZM.WS
|
+$214K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.12% |
| 2 | Energy | 0% |
Similar funds
CFGW
MCAV
RB
KCM
TM
SFS
POIA
VVM
CRCM LP's Q3 2024 Portfolio in Review
As of Q3 2024, CRCM LP held 7 positions worth $154M, up 12% from $138M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
CRCM LP deployed $33.6M of net new capital in Q3 2024, opening 1 new position and adding to 2 existing holdings. Its largest new stake was Singular Genomics Systems, Inc. Common Stock: 101,100 shares worth $1.58M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 11% a quarter earlier, followed by Energy.
On the sell side, the largest reduction was iShares Gold Trust, an estimated $37.6M trimmed.
- CRCM LP's largest Q3 2024 buy was Singular Genomics Systems, Inc. Common Stock: 101,100 shares worth $1.58M.
- CRCM LP added most to GRAIL Inc in Q3 2024, an estimated $38.6M increase.
- CRCM LP's biggest Q3 2024 reduction was iShares Gold Trust, cutting an estimated $37.6M.
- CRCM LP fully exited Grindr Inc. Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share in Q3 2024, selling an estimated $1.3M.
- CRCM LP's ten largest holdings make up 100% of its $154M portfolio in Q3 2024.
- CRCM LP opened 1 new position and closed 3 in Q3 2024.
- CRCM LP's portfolio value rose 12% quarter-over-quarter to $154M.
Based on CRCM LP's 13F filing for Q3 2024, filed 13 Nov 2024.